More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Managing psoriasis and psoriatic arthritis during the summer involves staying cool, using gentle skin care, and knowing what ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Tilt is a new makeup brand with products designed to make beauty accessible to everyone. It’s the first beauty brand and ...

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, ...

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for physicians, who highly prioritized individual symptoms, according to data ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

ALEXANDRIA, VA, UNITED STATES, February 4, 2025 /EINPresswire / -- The National Psoriasis Foundation (NPF) is pleased to announce an anonymous gift o ...

Not a lot of people know about psoriasis which is why several myths and misconceptions about the condition continue to ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...

No significant risk differences for major adverse cardiovascular events or venous thromboembolic events were observed in patients with psoriasis or psoriatic arthritis using biologic therapies. Use of ...